PE
TNDM icon

Point72 Europe’s Tandem Diabetes Care TNDM Stock Holding History

Point72 Europe’s Portfolio TNDM Stock Details TNDM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$19.1K Buy
+1,573
New +$21.3K ﹤0.01% 480

Other funds holding TNDM

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SC
Sessa Capital New York $5.51B AUM 47.23% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
GKIM
GW&K Investment Management Boston, Massachusetts $11.3B AUM 31.98% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
HRCM
Hood River Capital Management Palm Beach Gardens, Florida $9.98B AUM 145.42% 1-Year Est. Return
PIM
Paradice Investment Management Denver, Colorado $532M AUM 29.6% 1-Year Est. Return
FGP
Freestone Grove Partners San Francisco, California $14.2B AUM 24.58% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Point72 Europe's TNDM Position: Q3 2025 in Review

Point72 Europe opened a new position in Tandem Diabetes Care (TNDM) in Q3 2025: 1,573 shares worth $19.1K. The stake represents ﹤0.01% of the portfolio and ranks #480 among its holdings.

255 funds tracked by Wall St. Rank hold TNDM as of Q3 2025.

  • Point72 Europe held 1,573 shares of Tandem Diabetes Care worth $19.1K as of Q3 2025.
  • Tandem Diabetes Care was a new Point72 Europe position in Q3 2025.
  • Tandem Diabetes Care made up ﹤0.01% of Point72 Europe's portfolio in Q3 2025, its #480 holding.
  • 255 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q3 2025.

Based on Point72 Europe's 13F filing for Q3 2025, filed 14 Nov 2025.